The Medical Letter on Drugs and Therapeutics
FROM
ISSUE1555
ISSUE1555
September 10, 2018
Osmolex ER - Another Extended-Release Amantadine for Parkinson's Disease
Subscribers: Log in to read full article. Not a subscriber? Subscribe or purchase article. |
Osmolex ER - Another Extended-Release Amantadine for Parkinson's Disease
September 10, 2018 (Issue: 1555)
The FDA has approved an extended-release tablet
formulation of amantadine (Osmolex ER – Vertical/Osmotica) for once-daily treatment of Parkinson's
disease (PD) and drug-induced extrapyramidal
symptoms (EPS) in adults. An...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.